Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 8 studies | 34% ± 13% | |
GABAergic neuron | 3 studies | 29% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4170.06 | 2641 / 2642 | 100% | 91.51 | 703 / 705 |
prostate | 78% | 550.27 | 190 / 245 | 98% | 7.31 | 493 / 502 |
intestine | 74% | 904.34 | 719 / 966 | 88% | 9.42 | 462 / 527 |
esophagus | 65% | 405.62 | 944 / 1445 | 75% | 4.55 | 137 / 183 |
stomach | 62% | 363.29 | 221 / 359 | 78% | 8.22 | 223 / 286 |
uterus | 62% | 417.87 | 106 / 170 | 71% | 5.41 | 325 / 459 |
bladder | 48% | 343.19 | 10 / 21 | 50% | 3.73 | 254 / 504 |
breast | 30% | 159.00 | 139 / 459 | 66% | 3.82 | 735 / 1118 |
skin | 32% | 185.81 | 580 / 1809 | 47% | 2.92 | 223 / 472 |
eye | 0% | 0 | 0 / 0 | 76% | 4.14 | 61 / 80 |
lung | 10% | 48.45 | 58 / 578 | 58% | 3.79 | 675 / 1155 |
adrenal gland | 1% | 7.09 | 3 / 258 | 64% | 7.73 | 148 / 230 |
ovary | 17% | 103.47 | 30 / 180 | 42% | 2.29 | 180 / 430 |
tonsil | 0% | 0 | 0 / 0 | 53% | 2.88 | 24 / 45 |
pancreas | 1% | 2.17 | 2 / 328 | 44% | 1.88 | 79 / 178 |
adipose | 28% | 160.83 | 333 / 1204 | 0% | 0 | 0 / 0 |
thymus | 4% | 18.76 | 24 / 653 | 23% | 1.54 | 137 / 605 |
heart | 26% | 162.80 | 223 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 23% | 1.46 | 93 / 406 |
kidney | 6% | 23.31 | 5 / 89 | 13% | 0.93 | 116 / 901 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.14 | 2 / 29 |
blood vessel | 6% | 32.31 | 81 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 2.57 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071467 | Biological process | cellular response to pH |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0007269 | Biological process | neurotransmitter secretion |
GO_0008306 | Biological process | associative learning |
GO_0070207 | Biological process | protein homotrimerization |
GO_0046929 | Biological process | negative regulation of neurotransmitter secretion |
GO_0050915 | Biological process | sensory perception of sour taste |
GO_0010447 | Biological process | response to acidic pH |
GO_0006814 | Biological process | sodium ion transport |
GO_0001662 | Biological process | behavioral fear response |
GO_0007613 | Biological process | memory |
GO_0001975 | Biological process | response to amphetamine |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0009986 | Cellular component | cell surface |
GO_0160128 | Molecular function | pH-gated monoatomic ion channel activity |
GO_0015280 | Molecular function | ligand-gated sodium channel activity |
GO_0022839 | Molecular function | monoatomic ion-gated channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ASIC1 |
Protein name | Acid sensing ion channel subunit 1 Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2) |
Synonyms | BNAC2 ACCN2 |
Description | FUNCTION: Isoform 2 and isoform 3 function as proton-gated sodium channels; they are activated by a drop of the extracellular pH and then become rapidly desensitized. The channel generates a biphasic current with a fast inactivating and a slow sustained phase. Has high selectivity for sodium ions and can also transport lithium ions with high efficiency. Isoform 2 can also transport potassium, but with lower efficiency. It is nearly impermeable to the larger rubidium and cesium ions. Isoform 3 can also transport calcium ions. Mediates glutamate-independent Ca(2+) entry into neurons upon acidosis. This Ca(2+) overloading is toxic for cortical neurons and may be in part responsible for ischemic brain injury. Heteromeric channel assembly seems to modulate channel properties. Functions as a postsynaptic proton receptor that influences intracellular Ca(2+) concentration and calmodulin-dependent protein kinase II phosphorylation and thereby the density of dendritic spines. Modulates activity in the circuits underlying innate fear. .; FUNCTION: Isoform 1 does not display proton-gated cation channel activity. . |
Accessions | ENST00000552633.2 ENST00000228468.8 [P78348-1] P78348 ENST00000550558.5 H7C1W9 ENST00000453327.7 F8VSK4 ENST00000552438.5 [P78348-3] H0YHD6 ENST00000447966.7 [P78348-2] |